Mark C. Schneyer, EVP, Chief Financial Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 10,216 shares at $22.64 ($231K) on 2023-11-20, disclosed to the SEC on 2023-11-21.
Open-market sale of $231k ACAD by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.64 | 5,108 | $116K | 50.0% |
| 2 | $22.64 | 5,108 | $116K | 50.0% |
| Total | $22.64 avg | 10,216 | $231K | 100% |
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |